ASCO: Adding Pembrolizumab to Chemotherapy Improves Survival in Cervical Cancer
Overall and progression-free survival increased for persistent, recurrent, or metastatic cervical cancer by adding pembrolizumab to chemotherapy.
Overall and progression-free survival increased for persistent, recurrent, or metastatic cervical cancer by adding pembrolizumab to chemotherapy.
Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients?
Researchers assessed the relationship between the transition to menopause and weight gain among women with HIV infection.
Hysterectomy modifies risk for cancer but not equally for Black and White women and for both conditions.
Author reviews risk factors, diagnostic criteria, and treatment for postpartum cardiomyopathy as well as implications for future pregnancies.
A decision on the OTC oral contraceptive pill is expected later this year.
Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types.
Preeclampsia in pregnant women can lead to elevated blood pressure and require an early delivery, putting the mother and child at risk. Are there dietary factors that can help reduce preeclampsia risk, and are there factors that can increase it?
Women with higher-than-average breast cancer risk, especially Black and Ashkenazi Jewish women, should start screening at younger age.